|
|
Volumn 64, Issue 23, 2007, Pages 2406-
|
|
FDA approves new breast cancer treatment
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTHRACYCLINE;
CAPECITABINE;
CREMOPHOR;
DIPHENHYDRAMINE;
IXABEPILONE;
IXEMPRA;
RANITIDINE;
TAXANE DERIVATIVE;
UNCLASSIFIED DRUG;
ADVANCED CANCER;
BREAST CANCER;
CLINICAL TRIAL;
DRUG HYPERSENSITIVITY;
DRUG LABELING;
DRUG MECHANISM;
FATIGUE;
FOOD AND DRUG ADMINISTRATION;
HUMAN;
LIVER DISEASE;
METASTASIS;
NOTE;
PERIPHERAL NEUROPATHY;
PRIORITY JOURNAL;
TREATMENT RESPONSE;
WEAKNESS;
|
|
EID: 36749097311
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.2146/news07070097 Document Type: Note |
|
Times cited : (4)
|
|
References (0)
|